Managing EMVS EU-FMD alerts in a timely and GMP-compliant way is a legal obligation for every pharma manufacturer selling to the European market. Over two years […]
Putting patient safety first | How the Excellis Health Check and Brand Risk Assessment programme is helping pharma firms minimise security challenges In an age where […]
Article Updated 6th Jan A long winter… Just before the holidays we set the good news about the roll-out of COVID-19 vaccines gathering speed in context […]